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ABSTRACT
In Drosophila, the global increase in transcription
from the male X chromosome to compensate for
its monosomy is mediated by the male-specific
lethal (MSL) complex consisting of five proteins
and two non-coding RNAs, roX1 and roX2. After an
initial sequence-dependent recognition by the MSL
complex of 150–300 high affinity sites, the spread
to the majority of the X-linked genes depends
on local MSL-complex concentration and active
transcription. We have explored whether any add-
itional RNA species are associated with the MSL
complex. No additional roX RNA species were
found, but a strong association was found
between a spliced and poly-adenylated msl2 RNA
and the MSL complex. Based on our results, we
propose a model in which a non-chromatin-
associated partial or complete MSL-complex
titrates newly transcribed msl2 mRNA and thus
regulates the amount of available MSL complex by
feedback. This represents a novel mechanism in
chromatin structure regulation.
INTRODUCTION
Dosage compensation in Drosophila provides one of the
best examples of chromosome-wide gene regulation (1,2).
The compensation mechanism must fulﬁl two require-
ments. It must balance the relative expression between
sex chromosomes and autosomes and also equalize the
transcriptional activities of the two X chromosomes in
the homogametic sex with that of the single X chromo-
some in the heterogametic sex. Examination of X-linked
and autosomal gene expression in Drosophila,
Caenorhabditis elegans and mammals has revealed that
X-linked genes are expressed, on average, twice as
strongly as autosomal genes (3–5), implying that dosage
compensation involves compensation of X chromosome
expression not only between the two sexes, but also in
relation to the expression of autosomes. Thus, X inactiva-
tion in mammals might be considered as a response in
females to the overexpression of the X chromosome.
This overexpression is required by males because they
have just one X chromosome.
The male restricted 2-fold increase of X chromosome
gene expression in Drosophila fulﬁls both compensation
requirements described above. This seems to be
mediated by a general buffering mechanism for all mono-
somic regions, resulting in an  1.4-fold expression
increase (6–8) followed by an  1.35-fold expression
increase restricted to the X chromosome, mediated by
the MSL complex (7–10). In Drosophila melanogaster,
two non-coding RNAs, roX1 and roX2, have been
shown to be essential components of the dosage compen-
sation system. Together with at least ﬁve MSL proteins,
roX1 and roX2 form male-speciﬁc lethal (MSL) complexes
that ‘paint’ the male X chromosome, and mediate acetyl-
ation of H4 at lysine 16 on the male X chromosome, which
partly explains its subsequent hypertranscription (2,11).
Recent data suggest that the MSL complex, in addition,
have intrinsic properties that constrain the activation po-
tential of MOF (males absent on the ﬁrst) to end up with
the required 2-fold activation (12). The prevailing model
of the targeting process is that the MSL complex is re-
cruited to a set of 150–300 high-afﬁnity MSL recognition
elements (MRE) in a sequence-depending mechanism (13).
Subsequent spreading to neighboring genes with lower
afﬁnities depends on the local MSL-complex concentra-
tion (14), X chromosome location (15) and active tran-
scription (16,17). The sequence dependence of the
spreading remains poorly understood. Irrespective of dif-
ferences in transcript levels of genes and the transcription
requirements of different cells, a 2-fold transcriptional
up-regulation is required.
MSL2 protein is the limiting component for the forma-
tion of the MSL complex. In females, translation of msl2
mRNA is inhibited by the binding of the Sex lethal (Sxl)
protein in both the 50 and the 30-UTRs (18–20).
Overexpression of msl2 is toxic to females and becomes
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the overexpression of msl1, again highlighting the require-
ment for correct concentrations of the MSL complex
(12,19,21,22). Furthermore, association studies suggest
that MSL2 levels are tuned to match those of the other
MSL-complex components (23).
Although the roX genes are important for correct tar-
geting of the MSL complex, in roX1 roX2 double mutants
escaping males are recovered (22,24,25). This contrasts
with the absence of escaper males when the msl genes
are mutated. The partial viability of roX1 roX2 double
mutants could be explained by the presence of additional
roX RNA species (26,27), even though unsaturated screens
have failed to isolate such species (27,28). It has also been
hypothesized that MSL complex may bind to additional
RNAs produced by cryptic transcription as a mediator of
spreading (26).
Here we have used RNA-immunoprecipitation (RIP)
followed by tiling array analysis to determine the associ-
ation between the MSL complex and RNA moieties. We
found no additional ncRNA associated to the complex.
However, we observed a strong association between the
msl2 mRNA and a non-chromatin-associated MSL
complex. These data suggest a novel mechanism in chro-
matin structure regulation in which a non-chromatin-
associated form of a chromatin regulatory complex
attracts an intrinsic rate-limiting mRNA and thus regu-
lates the amounts of the complex available for chromatin
targeting by feedback.
MATERIALS AND METHODS
Immunostaining and in situ hybridization of polytene
chromosomes
Polytene chromosomes from the salivary glands of
third-instar larvae were prepared and stained essentially
as previously described (29). Salivary glands were ﬁxed in
2% formaldehyde in PBS, 0.1% Triton X-100, 0.2%
NP-40 for 40s followed by 2–3min in 50% acetic acid,
1% formaldehyde. Polytene chromosomes were squashed
as previously described (30). The slides were washed for
30min in 1  PBS, 0.1% Triton X-100, transferred to
blocking solution (0.1M maleic acid, 0.15M NaCl, 1%
Boehringer blocking reagent) and incubated for 30min
at room temperature. The slides were then incubated over-
night at 4 C with primary antibody raised against MSL2
(1:300), MSL3 (1:2000) or MLE (1:2000). The slides were
washed 2  10min in 0.1M maleic acid, 0.15M NaCl,
0.3% Tween-20 and blocked for 30min. Donkey
anti-rabbit and anti-goat (Jackson Laboratories)
conjugated with Cy3 or FITC (diluted 1:400) were used
as secondary antibodies and incubated at room tempera-
ture for 2h. The squashes were counterstained with DAPI
(1mg/ml) and washed 2  10min before mounting with
Vectashield (Vector). Preparations were analyzed using a
Zeiss Axiophot microscope equipped with a KAPPA
DX20C charge-coupled device camera. Images were
assembled and merged electronically using Adobe
Photoshop. For in situ hybridization, the slides were
prepared as above and hybridized and washed essentially
as previously described (31). The slides were hybridized
against a DIG-labeled antisense RNA probe against
roX1 (GH10432) or msl2 (GH22488). The DIG-labeled
probe was detected using sheep anti-Digoxigenin
(0.4mg/ml, Roche) followed by donkey–anti-sheep conjug-
ated with AlexaFluor555 (Molecular Probes, diluted
1:500) and DAPI counterstaining. roX1 roX2 double
mutant males were selected as non-GFP males from a
yw roX1
ex6 Df(1)roX2
52 P[w
+4D4.3]/ FM7i,P[w
+mC
ActGFP]JMR3 stock. Females and males overexpressing
msl2 were selected from a w; P[w
+ hsp83:msl2]
msl3/TM6B stock.
Immunostaining and in situ hybridization of S2-cells
Schneider’s line 2 cells (ATCC CRL-1963) were grown as
a suspension culture at 25 C in Erlenmeyer ﬂasks to a
density of 1 10
7 cells/ml in Drosophila SFM medium
(Invitrogen), supplemented with 100U/ml Penicillin G,
100mg/ml Streptomycin sulfate and 2mM of L-glutamine.
0.2 10
7 cells were placed on Polysine slides (VWR) and
incubated at room temperature for 1h. The cells were
ﬁxed for 10min with 2% formaldehyde in PBS and
permeabilized with 0.1% Triton X-100 in PBS for
10min at room temperature. The slides were washed
twice in 70% ethanol before dehydration at 80, 95 and
99.5% ethanol and then air dried. The slides were
hybridized and washed as described above using
DIG-labeled antisense RNA probes against roX1
(GH10432), roX2 (GH18991), msl2 (GH22488) or CkII 
cDNA and immunostained in parallel with anti-MSL1
(1:500).
RIP-chip
For each sample treatment condition, we used 300ml
cultured D. melanogaster Schneider’s line 2 cells. The
cells were pelleted, washed twice in 100ml 10mM
HEPES pH 7.4, 140mM NaCl and resuspended in 50ml
of lysis buffer (20mM HEPES pH 7.4, 3mM MgCl2,
0.1% Triton X-100, 1mM dithiothreitol, 0.5mM PMSF,
10U/ml RNasin and 0.5  complete protease inhibitor
cocktail, Roche). The cells were allowed to swell on ice
for 10min and then homogenized on ice with 30 strokes of
a Dounce homogenizer. The nuclei were pelleted at 2000g
for 5min and used either as native samples (non-cross-
linked) or after formaldehyde cross-linking. For the
cross-linked sample (FA), the pelleted nuclei were resus-
pended in 50ml lysis buffer and cross-linked by adding
formaldehyde to a ﬁnal concentration of 0.5% and
incubated for 10min at room temperature. The cross-
linking was stopped by adding glycine (ﬁnal concentration
0.125M), the nuclei were washed once in lysis buffer and
resuspended in 2ml of sonication buffer (20mM HEPES
pH 7.4, 10% glycerol, 0.1M NaCl, 1mM MgCl2, 0.1%
Triton X-100, 1mM dithiothreitol, 0.5mM PMSF,
10U/ml RNasin and 0.5  Protease inhibitor cocktail)
and sonicated using a Bioruptor (Diagenode) for 4min
at high setting (30s ON, 30s OFF). For the native
samples the pelleted nuclei were resuspended in 2ml son-
ication buffer and sonicated for 1, 3 or 6min (N1, N3 and
N6, respectively). Cellular debris was removed by
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natants were used for immunoprecipitations.
For immunoprecipitation, 1–2mg nuclear extracts were
incubated with 5ml anti-MSL2, 5ml anti-MOF or no
antibody for 45min at 4 C, with agitation. The antibody
complexes were precipitated by incubation with 75mlo f
Dynabeads conjugated to protein-A (Invitrogen) for
30min at 4 C, with agitation. The supernatant was
removed and the beads were washed twice with PBS
(150mM NaCl), 0.1% Triton X-100, 32U/ml RNasin,
0.5  Protease inhibitor cocktail and twice in PBS
(300mM NaCl), 0.1% Triton X-100, 32U/ml RNasin,
0.5  Protease inhibitor cocktail. The cross-linking in FA
samples was reversed by adding 200ml 0.45M LiCl to the
beads and incubating for 3–4h at 65 C. RNA was isolated
using TRI-reagent (Ambion), followed by puriﬁcation
using an RNeasy kit (Qiagen) according to the instruc-
tions by the suppliers. The RNA samples were
concentrated and reverse-transcribed into cDNA using
random primers with an ImPromII ﬁrst-strand synthesis
kit (Promega). The single-stranded cDNA was puriﬁed
with a QIAquick PCR puriﬁcation Kit (Qiagen) then the
puriﬁed cDNA samples were ampliﬁed using a WGA2
GenomePlex Complete whole genome ampliﬁcation
kit (Sigma), according to the manufacturer’s
recommendations.
For tiling array analysis, ampliﬁed DNA samples were
fragmented, labeled and hybridized to an Affymetrix
Drosophila Genome 2.0 array. The signal intensity data
were analyzed with the Affymetrix Tiling Analysis
Software (v. 1.1.02) using 90bp bandwidth and perfect
match only. For absolute amount analysis (transcript
proﬁle), the bandwidth was set to zero. RNA enrichment
ratios for all genes in nuclear extract N6 were calculated as
the average enrichment ratio value of all probes located
within exons of each gene. Total amounts of nuclear gene
transcript were calculated from the corresponding input
sample as the average value of all probes located within
exons of each gene. Only genes with at least 10 probes
within exons were included. For the comparison of our
RIP proﬁles to MSL-complex binding proﬁle the
ChIP-chip data for MSL1, MSL3 and MOF from (32)
were downloaded from the ArrayExpress database (acces-
sion number M-EXP-1508). The signal intensity data were
analyzed with the Affymetrix Tiling Analysis Software
(v. 1.1.02) using parameters: 300bp bandwidth and
perfect match only. The data were converted to
D. melanogaster genomic release 5 using the Coordinates
Converter Tool at FlyBase (33).
RIP-qPCR
Three biological replicates of native nuclear preps from
Schneider’s line 2 cells (ATCC CRL-1963) were
prepared as described above. The nuclei were washed
once in lysis buffer and fractionation into nucleoplasm
and chromatin was done essentially as described in (34).
The pelleted nuclei were resuspended in 2ml nuclear lysis
buffer (20mM HEPES pH 7.9, 3mM EDTA, 10%
glycerol, 150mM KAc, 1.5mM MgCl2, 0.1% Triton
X-100, 1mM dithiothreitol, 0.5mM PMSF, 20U/ml
RNasin and 1 Protease inhibitor cocktail) and
centrifuged at 14000g for 30min at 4 C. The supernatant
was collected as the nucleoplasmic fraction. The pelleted
chromatin was resuspended in 2.8ml of nuclear lysis
buffer and solubilized by sonication for 6min at high
setting (30s ON, 30s OFF). Cellular debris was removed
by centrifugation at 14000g for 20min at 4 C and the
supernatants were collected as the chromatin fractions.
For immunoprecipitation, 5–10mg nucleoplasmic and
corresponding cytoplasmic extracts, respectively, were
incubated with 5ml anti-MSL2 (replicate A) or 2ml
anti-MSL2 serum (replicate B and C) for 45min at 4 C
with agitation. The antibody complexes were then
precipitated as described above. RNA was isolated using
TRI-reagent (Ambion), followed by DNase treatment
using TURBO DNA-free kit (Ambion) and puriﬁcation
using an RNeasy kit (Qiagen) according to the manufac-
turer’s instruction. For replicate C, poly(A)
+ RNA was
isolated using Dynabeads Oligo (dT)25 (Invitrogen) in
line with the instruction by the suppliers. The RNA
samples were reverse-transcribed into cDNA using
iScript cDNA synthesis kit (Bio-Rad).
The RIP cDNA and the corresponding total cDNA
were quantiﬁed by real-time PCR using SYBR green
supermix (Bio-Rad). The primer pairs used were: roX1
(50-TACCGCTCTCTTTCGGGACTTG-30,5 0-TCCATC
ACTCTCTATCGGGCTG-30), roX2 (50-GGCCATCGA
AAGGGTAAATTG-30,5 0-ACTGTCCGTAAGACAAT
TCAAC-30), msl2 (50-CTGGACACGAATAGTGAA
GCC-30,5 0-TTGCAGCAATCCCAGCATC-30), actin
(50-CAGCCAGCAGTCGTCTAATC-30,5 0-ACAACCA
GAGCAGCAACTTC-30) and Rpl32 (50-CGATGTTGG
GCATCAGATAC-30,5 0-CCCAAGATCGTGAAGAAG
C-30). The relative enrichment levels were calculated in
relation to actin cDNA in each replicate.
RESULTS
To determine the potential association of the MSL
complex with RNA moieties in an unbiased procedure,
we performed RIP experiments on nuclear extracts from
S2 cells, with and without cross-linking, followed by
tiling-array analysis (RIP-chip) (Figure 1). For the RIP
experiment, we chose MSL2 as a representative of the
MSL-complex scaffold (consisting of MSL1 and MSL2)
required for the complex to bind DNA and MOF as a
representative of the complex members required for
spreading (1,35).
MSL-complex associates with roX1 and roX2 RNAs
from the X chromosome
We ﬁrst investigated the enrichment of RNAs transcribed
from the X chromosome in the MSL2- and MOF-RIPs.
We found that, as predicted, roX1 and roX2 are highly
enriched in the complex (Figure 1). We found no
evidence of any additional X-linked non-coding RNA
associated with the MSL complex when roX1 and roX2
are present (Figure 1). Neither did we ﬁnd any evidence
that the MSL-complex attracts any cryptic RNA species
produced at the MREs. The overall enrichment levels of
6430 Nucleic Acids Research, 2011,Vol.39, No. 15the X chromosome and the autosomes are comparable
(Supplementary Figure S1). In the formaldehyde ﬁxed
samples (FA), X chromosome transcripts in general were
enriched compared with transcript on other chromosomes.
We therefore compared our RIP-chip data with available
ChIP-chip data representing the MSL-complex bind-
ing proﬁle. The results showed that the RIP from the
native nuclear extract is highly enriched in roX RNAs
while the RIP experiment from the formaldehyde
cross-linked nuclear extract is in addition enriched in
transcripts from genes targeted by the MSL complex
(Figure 2A–C). This is probably a consequence of
cross-linked chromatin fragments including RNA
moieties linked by active transcription.
A detailed analysis of the roX1- and roX2-precipitated
RNAs shows that the entire roX1 and roX2 RNAs are
immunoprecipitated by antibodies against both MOF
and MSL2 (Figure 2D–E and Supplementary Figure
S2). A higher enrichment of roX2 compared to roX1 was
observed in all conditions except in the formaldehyde
cross-linked sample, suggesting that roX2 is more stably
bound to the complex in S2 cells.
The MSL complex is strongly associated with nuclear
msl2 mRNA
It is well established that the roX genes can exert their
activity in trans as well as in cis (24). We, therefore,
asked whether any autosomal RNA has a stable associ-
ation with the MSL complex. Visual inspection of enrich-
ment curves readily identiﬁed a second target with a
comparable enrichment ratio to roX1 and roX2, namely
the msl2 transcript itself (Figure 3A). A ranking of all
nuclear transcripts according to their mean enrichment
ratio showed that msl2 binding is indeed comparable
with the roX enrichments. Furthermore, msl1 also scored
highly in this ranking, although much lower than roX1,
roX2 and msl2 (Figure 3B and Supplementary Figure S3).
It should be stressed that not only the enrichment ratio
but also the absolute amount of msl2 RNA pulled down
with the MSL complex are comparable to roX levels
Figure 1. MSL-complex associates with roX1 and roX2 RNAs transcribed from the X chromosome. (A) Schematic outline of the RIP method. N1,
N3 and N6 correspond to native nuclear extracts sonicated for 1, 3 and 6min, respectively. FA corresponds to formaldehyde-cross-linked nuclear
extract. (B) The tiling array results are computed as the ratio between the RIP value and the value of the corresponding nuclear input RNA
preparation; MSL2-RIPs (blue), MOF-RIPs (green). Ratios calculated between the RIP values and a MOCK-RIP (instead of input) yield comparable
results (data not shown). The plots show the mean enrichment ratios obtained using a bandwidth of 90bp. Numbers on the x-axis denote chromo-
somal position along the X chromosome in kilobase. The y-axis shows the RIP enrichment as the log2-ratio. In the resulting proﬁle, enrichments >1
(which correspond approximately to the top 1% of binding) are shown. Genes expressed from left to right are shown above the horizontal line and
genes expressed in the opposite direction are shown below the line. The high peaks within the yellow boxes are roX1 and roX2, respectively. Below
the enrichment plots, the MRE sites are indicated (orange) as previously characterized by (13). No signiﬁcant correlation of immunoprecipitated
RNAs to MREs was found.
Nucleic Acids Research, 2011,Vol.39, No. 15 6431Figure 2. Entire roX1 and roX2 mRNAs are associated with a complete or partial MSL complex. (A–C) In formaldehyde cross-linked extracts,
actively transcribed RNAs are immunoprecipitated by chromatin-associated proteins. Comparison of a ChIP-chip proﬁle representing the MSL
complex (MSL1-ChIP) and the MSL2 RIP-chip proﬁles from the native nuclear extract (MSL2 N6-RIP) and formaldehyde-cross-linked nuclear
extract (MSL2 FA-RIP). Representative 400kb regions from the X chromosome including roX1 (A) and roX2 (B) are compared to a representative
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(continued)(Figure 3B and Supplementary Figure S3). We asked
whether the msl2 and msl1 RNAs were pulled down by
free MSL2 protein, or by MSL2 associated with the MSL
complex. Notably, roX1 and roX2 RNAs are enriched at
similar levels in both MSL2-RIP and MOF-RIP. In
contrast, msl2 RNA is enriched in both RIPs but at
higher levels in the MSL2-RIP than in the MOF-RIP
(compare Figure 2D–E with Figure 3C). The results
suggest that msl2 RNA is associated with a less stable
MSL complex. Still, since the MOF-RIP also shows high
enrichment of msl2 and msl1 RNA, we conclude that msl2
and msl1 RNAs are associated with a partial or complete
nuclear MSL complex (Figure 3C and Supplementary
Figure S4). We have not found any signiﬁcant sequence
identities or predicted secondary structure similarities
between msl2 and roX1 or roX2.
msl2 RNA is bound by a non-chromatin-associated MSL
complex
We considered two plausible models to account for a po-
tential function for the strong association of a nuclear
complete or partial MSL complex with the msl2 RNA.
First, msl2 may aid the correct targeting of the MSL
complex, by functioning similarly to roX. Second, since
the local concentration of MSL complex is important
for spreading and therefore for the correct regulation of
most X-linked genes, we can hypothesize that the
non-chromatin bound fraction of the MSL complex
titrates the msl2 RNA. A combination of these two
models is also possible. Recalling that the roX RNAs
coat the male X chromosome, co-localizing with MSL
complex, we performed in situ hybridization with RNA
probes against roX1 and msl2. As previously shown,
roX1 decorates the male X chromosome in a similar
pattern to the MSL complex. However, we did not
observe chromatin-associated msl2 RNA in the wild-type
(Figure 4A). Previously, a co-transcriptional assembly of
the MSL complex at the roX loci has been suggested
(1,27,36). In contrast, the MSL complex is not found at
the msl2 locus in published ChIP-chip analysis
(Supplementary Figure S5). This indicates that the associ-
ation of MSL complex with msl2 RNA is not
co-transcriptional.
We speculated that a loss of roX1 roX2 and/or
overexpression of msl2 may enhance an intrinsic
property of the msl2 RNA to be included in the
chromatin-associated MSL complex. In roX1 roX2
mutant males, MSL complex is still detected at a
reduced number of sites on the X chromosome, but
strong binding is also reproducibly found in the
Figure 2. Continued
400kb region from chromosome 3R (C). The plots show the mean enrichment ratios obtained using a bandwidth of 300bp for the MSL1 ChIP-chip
and a bandwidth of 90bp for the MSL2 RIP-chip. Numbers on the x-axis denote chromosomal position along the chromosome in kb. The y-axis
shows the ChIP and RIP enrichments, respectively, as the log2 ratio. Genes expressed from left to right are shown above the horizontal line and
genes expressed in the opposite direction are shown below the line. The roX1 and roX2 loci are indicated by yellow boxes. The MSL1 ChIP data is
from (32). (D and E) High resolution enrichment proﬁles of MSL2-RIP and MOF-RIP at the rox1 (D) or roX2 (E) locus. Exons are indicated in
black and introns in grey. The different transcript forms of roX1 and roX2 are indicated. The described DNAse hypersensitive regions and roX-boxes
suggested to be of functional importance (36,51–53) are indicated as deep-purple and yellow boxes, respectively. We observed a general enrichment of
the entire mRNA and no obvious speciﬁcity to parts of the RNAs.
Figure 3. MSL complex is strongly associated with nuclear msl2
mRNA. (A) High resolution enrichment proﬁling along chromosome
2L shows that msl2 is enriched in the MSL2-RIP at similar ratios to
roX1 and roX2. The high peaks within the yellow boxes correspond to
msl2 (left box) and msl1 (right box). (B) Average calculated enrichment
levels of genes (x-axis) plotted against the average amount of nuclear
transcript (y-axis, log2 scale) for all genes with at least 10 probes within
exons. roX1, roX2 and msl2 clearly ordinate as highly enriched. Note
that the absolute amount of msl2 RNA pulled down is similar to the
absolute amounts of the roX RNAs. (C) The entire msl2 mRNA is
associated with a complete or partial MSL complex. High resolution
enrichment proﬁles of MSL2-RIP (blue) and MOF-RIP (green) at the
msl2 locus. The msl2 gene is transcribed from right to left and the
different splice forms are indicated. Numbers on the x-axis denote
chromosomal position along the X chromosome in kilobase. The
y-axis shows the RIP enrichment as the log2 ratio.
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chromosome (Figure 4B and Supplementary Figure S6)
(24,37). Notably, the speciﬁc sites on the fourth chromo-
some targeted by the MSL complex in roX1 roX2 mutants
are also targeted weakly by the MLE protein alone in
wild-type, both in males and females (Supplementary
Figure S7). We hybridized roX1 roX2 mutant male
larvae with and without overexpression of msl2 and
wild-type males with overexpression of msl2. In none of
these cases did we detect msl2 RNA linked to the X
chromosome, in the chromocenter, or the highly speciﬁc
sites on the fourth chromosome (Figure 4C and
Supplementary Figure S8).
In the RIP experiments performed on S2 cells a strong
enrichment of msl2 RNA in the MSL complex was
detected. To test if msl2 is included in an X
chromosome-associated MSL complex in S2 cells, we per-
formed in situ hybridizations on these cells (Figure 5).
Figure 4. In polytene chromosomes, msl2 RNA is not associated with the chromatin bound MSL complex. (A) In situ hybridization shows that roX1
decorates the male X chromosome (top row of images). No msl2 RNA associated with the wild-type male X chromosome is detected (bottom row of
images). (B)I nroX1 roX2 mutant males MSL2 and MSL3 target the chromocenter and three speciﬁc sites on the fourth chromosome. Merged
images of immunostainings showing DAPI in blue, MSL3 in green and MSL2 in red. The chromocenter is indicated by an arrow and the speciﬁc
sites on the fourth chromosome with arrowheads (Supplementary Figure S6). (C) Merged images from in situ hybridization with msl2 RNA antisense
probe on males overexpressing msl2 (left panel), roX1 roX2 mutant males (middle) and roX1 roX2 mutant males overexpressing msl2 (right)
(Supplementary Figure S8).
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protein on the X chromosome. In agreement with the
results from salivary glands we did not ﬁnd any enrich-
ment of msl2 RNA on the X chromosome in S2 cells,
indicating that the msl2 RNA associates to a non-
chromatin bound MSL complex. Strong roX2 hybridiza-
tion was observed on the X chromosome territories in all
cells. Interestingly, roX1 hybridization was as strong, but
only detected in a small fraction of cells (<0.5%). This
suggests that the observed low expression of roX1 in S2
cells is due to expression in few individual cells and not a
general low expression level in all cells.
Next, we performed a crude fractionation of nuclei into
a chromatin fraction and a nucleoplasmic fraction and
determined the relative levels of roX1, roX2 and msl2 by
qPCR. The results show that the majority of both roX1
and roX2 RNAs are located in the chromatin fraction
while the msl2 transcripts are primarily found in the nu-
cleoplasm (Figure 6A–C). MSL2-RIP experiments using
the nucleoplasmic fractions show very strong enrichments
of roX1, roX2 and msl2 RNA, verifying the nuclear
RIP-chip data. Gel electrophoresis of the RIP experiment
qPCR products shows that the MSL complex-associated
msl2 RNAs are spliced. The results also show that the
msl2 RNA associated to the MSL complex is
poly-adenylated, since msl2 RNA is enriched to the same
extent when using poly-adenylated RNA (Figure 6C) as
when using total RNA (Figure 6A–B) in the analysis. To
exclude that the enrichment of msl2 RNA in the nucleo-
plasm is caused by contaminating cytoplasm, we per-
formed MSL2-RIP also on corresponding cytoplasmic
fractions. Weak enrichments of roX and msl2 RNAs
were detected in the cytoplasm but much lower than the
enrichments found in corresponding nucleoplasm
(Supplementary Figure S9). We conclude that a spliced
poly-adenylated msl2 RNA associates with a
nucleoplasmic complete or partial MSL complex.
DISCUSSION
For many chromatin-associated factors, the relative con-
centrations direct their binding. Thus, correct targeting
will strictly depend on the concentration of these protein
Figure 5. In S2 cells, msl2 RNA is not associated with the chromatin bound MSL complex. Immunostaining and in situ hybridization show that
roX2 (yellow) decorates the X chromosome identiﬁed by MSL1 (green). Note that roX1 decorates the X chromosome in a small fraction of cells
(<0.5%). Nuclei are visualized with DAPI. Neither the msl2 RNA nor the negative control CkII  RNA are enriched on the X chromosome. In each
row, the location of one X chromosome in a representative cell is indicated with an arrow.
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restricted to males by a translational block caused by Sxl
protein binding to the msl2 RNAs. However, it has been
suggested that Sxl binds not only all msl2 transcripts, but
also to a subset of msl1 transcripts and prevents their
translation in females (19). This reﬂects the potential of
these two RNAs to be regulated through speciﬁc protein
interactions. These two RNAs encode the core of the
dosage compensation complex. Here, we provide
evidence that a non-chromatin bound fraction of the
MSL complex has high afﬁnity for nuclear msl2 mRNA
and also afﬁnity for nuclear msl1 mRNA. Based on this,
we propose a novel mechanism for ﬁne-tuning the MSL
complex concentration by feedback.
We have used both formaldehyde ﬁxed nuclear extracts
and native nuclear extracts in our RIP experiments. In
both these sample types, we detected strong enrichments
of roX1, roX2 and msl2 transcripts. In the native extracts,
we could not detect signiﬁcant enrichment of RNA
transcribed from genes targeted by the MSL complex
nor any enrichment of RNA molecules transcribed from
MREs. Although, we found robust enrichment of roX1
Figure 6. Spliced and poly-adenylated msl2 RNA is associated to a non-chromatin bound MSL complex. (A–C) Fractionation and RIP experiments
of three biological replicates using total RNA extraction (A and B) and extracted poly(A)
+ RNA (C). The circle diagrams specify the relative
proportion of the RNAs in the nucleoplasm (gray) and the chromatin fractions (dark gray). The majority of the roX1 and roX2 RNAs are located in
the chromatin fraction while msl2 and the negative control Rpl32 are mainly found within the nucleoplasm. As illustrated in the histograms,
enrichment of msl2 RNA in the MSL complex is conﬁrmed by RIP experiments on the nucleoplasmic fractions using MSL2 antibodies.
Displayed are the fold enrichments relative to actin RNA. Immunoprecipitated msl2 in experiments A, B and C correspond to 3, 4 and 10% of
input, respectively. Gel-electrophoretic analyses of ampliﬁed genomic DNA (gDNA), immunoprecipitated (NP RIP) and total RNA from the
nucleoplasm (NP) and from chromatin (Chr) fractions show that msl2 RNAs associated to the MSL complex are spliced. The PCR product sizes
of the spliced msl2 amplicon and the unspliced amplicon are indicated by arrowheads and stars, respectively. The minus reverse transcriptase controls
(-RT) are shown below. (D) Model for feedback regulation of MSL complex via the association of a non-chromatin MSL complex with the msl2
mRNA. When free nuclear MSL complex is present this non-chromatin MSL-complex titrates msl2 RNA and thus reduces the amount of msl2
transcript available for export and translation, which in turn regulates the complex production as a feedback mechanism.
6436 Nucleic Acids Research, 2011,Vol.39, No. 15and roX2 we did not ﬁnd any additional roX RNA that
could explain the escape of male lethality seen in roX1
roX2 double mutants. It should be stressed that it is still
possible that a roX-like encoding gene is harbored in the
heterochromatic regions which are not fully covered by
the tiling arrays. Alternatively, several different RNAs
may substitute for roX1 and roX2 but with much lower
afﬁnity or the MSL complex can exert its function without
an RNA molecule. In contrast, in the formaldehyde ﬁxed
sample we detected enrichments of transcripts from genes
targeted by the MSL complex. We conclude that RIP
using formaldehyde cross-linked extracts will be enriched
in RNA species directly linked to the targeted protein as
well as nascent RNA molecules linked via chromatin and
active transcription. This is important to consider when
using formaldehyde ﬁxation in RNA immunoprecipitation
experiments.
We describe two potential functions for the strong as-
sociation of a nuclear MSL complex with the msl2 RNA.
First, msl2 may aid the correct targeting of the MSL
complex, by functioning similarly to roX. This could
have been a function in a more ancient form of the
MSL complex and may in part have been retained
during evolution. In favour of this model is the fact that
roX1 roX2 double mutations are not completely male
lethal, in contrast to msl mutations. The elevation of
cellular levels of MSL1 and MSL2 that partially
suppress roX1 roX2 male lethality, also supports this
model. Second, since the local concentration of MSL
complex is important for spreading and, therefore, also
for the correct regulation of most X-linked genes, we
can hypothesize that the non-chromatin bound fraction
of the MSL complex titrates the msl2 RNA. Thus, this
process would regulate the amount of MSL2 protein and
assembled MSL complex, as a feedback mechanism.
Since the msl2 RNA is highly enriched in a nuclear but
not chromatin-associated MSL complex, we hypothesize
that this interaction functions as a feedback control that
avoids elevated MSL-complex levels and compensates for
overshooting (Figure 6D). It has been observed that
ectopic expression of an msl2-GFP transgene led to reduc-
tion of the endogenous MSL2 protein levels (23). This is in
line with what would be predicted from a feedback mech-
anism as hypothesized here. The classical example of
self-mRNA targeting of proteins is from Escherichia coli,
in which the ribosomal proteins bind to their mRNA and
inhibit translation. The ribosome biogenesis can thus be
regulated solely through the amount of rRNA which syn-
thesis rate becomes rate limiting for ribosome assembly.
As long as the process of ribosome assembly requires ribo-
somal proteins, the corresponding mRNAs will escape
translation inhibition (38). Intrinsic association of RNA
in chromatin regulation has been reported for the yeast
SET1C histone methyl transferase complex. In this case,
the association is linked to co-translational assembly of
the complex (39).
The dosage compensation system is under strong evo-
lutionary pressure to respond as new genes, chromosome
regions or chromosome arms join the X chromosome and
it has been shown that the MSL proteins are under
adaptive evolution (40). Interestingly, strong positive
selection was detected in MSL1 and MSL2 protein
domains shown to be responsible for their speciﬁc target-
ing to the X chromosome (41,42). Positive selection has
also been shown to act on the MSL binding sites (43). This
means that the dosage compensation system is under
constant pressure to adapt to emerging changes. The
target sequences are under constant selection as are the
targeting proteins, in particular MSL1 and MSL2. Thus,
the concentration requirements will also need constant ad-
justments. A feedback module based on association of a
rate limiting mRNA would provide an optimal target for
evolution to act on in order to provide a dynamic
ﬁne-tuning of complex concentration, and therefore,
correct targeting. This may explain the afﬁnity of the
MSL complex to both msl1 and msl2 RNAs which
encode the core proteins for a functional complex. At
limiting concentrations of freely diffusible proteins and
protein complexes only the sites with highest afﬁnity will
bind while at high concentrations even sites with low
afﬁnity will bind. It should be stressed that chromatin-
associated factors are often described to be highly sensitive
to correct dose (44,45). This is observed for the
Polycomb-group proteins involved in maintaining repres-
sion of homeotic genes (46,47) as well as for suppressors of
variegation, important for heterochromatin formation
(48–50). In both these cases many loci exhibit dosage
effects, indicating strict dosage needs. As more RNA
immunoprecipitation data are produced it is likely that
the msl2 titration reported here is just one example of a
general self-afﬁnity module important for feedback
regulation.
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